comparemela.com

Kerry Clem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RoadMap Technologies Achieves HITRUST Risk-based, 2-year Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements

Acorda Therapeutics (ACOR) Announces Esteve Launches INBRIJA in Germany

Acorda Therapeutics (ACOR) Announces Esteve Launches INBRIJA in Germany
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Esteve Launches INBRIJA in Germany

16.06.2022 - Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Esteve Pharmaceuticals GmbH has launched INBRIJA 33 mg (levodopa inhalation powder, hard capsules) in Germany. INBRIJA is indicated in the EU for the intermittent treatment of episodic . Seite 1

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.